Dihydropyrimidine dehydrogenase testing: capturing what standard genotyping misses with next-generation sequencing

NGS analysis enables the identification of <i>DPYD</i> rare or structural variants with potential functional impact, thereby improving the genetic assessment of DPD deficiency.

Authors

Institutions

Publication Details

Journal
Pharmacogenomics
Published
2025-12-12
DOI
https://doi.org/10.1080/14622416.2026.2613869
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dihydropyrimidine dehydrogenase testing: capturing what standard genotyping misses with next-generation sequencing

C. Tron, Nicolas Picard, Dorian Chastagner, Mohamed Ksentini et al.
Pharmacogenomics
Colorectal Cancer Treatments and Studies
article

Dihydropyrimidine dehydrogenase testing: capturing what standard genotyping misses with next-generation sequencing

C. Tron, Nicolas Picard, Dorian Chastagner, Mohamed Ksentini, Maxime Sourdioux
article en

Abstract

NGS analysis enables the identification of <i>DPYD</i> rare or structural variants with potential functional impact, thereby improving the genetic assessment of DPD deficiency.

PharmacogenomicsVol. 26(17-18)
Université Rennes 2 (FR), Centre Hospitalier Universitaire de Limoges (FR), Centre Hospitalier Universitaire de Rennes (FR), Université de Rennes (FR), Université de Limoges (FR)
Openalex Percentile: Top 28%
Colorectal Cancer Treatments and Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.